Inhibition of P-Glycoprotein Transport Function by Grapefruit Juice Psoralen
Purchase on Springer.com
$39.95 / €34.95 / £29.95*
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.
Purpose. The grapefruit juice component bergamottin is known to inactivate cytochrome P450 3A4, with grapefruit juice consumption causing increased absorption and enhanced oral bioavailability of many cytochrome P450 3A4 substrates. Many of these substrates are also recognized by the efflux transporter P-glycoprotein. The gene product of MDR1 (multidrug resistance transporter), P-glycoprotein also confers protection against xenobiotics.
Methods. Using a whole cell assay in which the retention of a marker substrate is evaluated and quantified, we studied the ability of grapefruit juice components to inhibit the function of this transporter.
Results. In a cell line presenting an overexpressed amount of the human transporter, the enzyme exhibited a 40 μM IC50 for inhibition by bergamottin. Additionally, using the ATP-hydrolysis assay, we showed that bergamottin increases P-gp-mediated ATP hydrolysis by approximately 2.3 fold with a Km of 8 μM. The concentration for this interaction is similar to that for CYP3A4 inactivation.
Conclusions. These results suggest that observed grapefruit juice - drug pharmacokinetic clinical interactions may be due to P-gp inhibition rather than or in addition to CYP3A4 inhibition. Inhibition of P-gp by citrus psoralens could present ways both to enhance bioavailability of therapies without increasing the dose and to diminish drug resistance in refractory cells.
- I. Pastan and M. Gottesman. Multiple-drug resistance in human cancer. N. Engl. J. Med. 316:1388-1393 (1987).
- M. M. Gottesman and I. Pastan. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem. 62:385-427 (1993).
- P. Gross and E. Buschman. The mouse multidrug resistance gene family: Structural and functional analysis. Int. Rev. Cytol. 137C:169-197 (1993).
- U. A. Germann. P-glycoprotein—A mediator of multidrug resistance in tumour cells. Eur. J. Cancer 32A:927-944 (1996).
- M. M. Gottesman, I. Pastan, and S. V. Ambudkar. P-glycoprotein and multidrug resistance. Curr. Opin. Genet. Dev. 6:610-617 (1996).
- A. B. Shapiro and V. Ling. Reconstitution of drug transport by purified P-glycoprotein J. Biol. Chem. 270:16167-16175 (1995).
- F. J. Sharom, X. Yu, and C. A. Doige. Functional reconstitution of drug transport and ATPase activity in proteoliposomes containing partially purified P-glycoprotein. J. Biol. Chem. 268:24197-24202 (1993).
- F. J. Sharom, X. Yu, G. DiDiodato, and J. W. K. Chu. Synthetic hydrophobic peptides are substrates for P-glycoprotein and stimulate drug transport. Biochem. J. 320:421-428 (1996).
- A. B. Shapiro and V. Ling. Extraction of Hoechst 33342 from the cytoplasmic leaflet of the plasma membrane by P-glycoprotein. Eur. J. Biochem. 250:122-129 (1997).
- E.-J. Wang, C. N. Casciano, R. P. Clement, and W. W. Johnson. Two transport binding sites of P-glycoprotein are unequal yet contingent: Initial rate kinetic analysis by ATP hydrolysis demonstrates intersite dependency. Biochim. Biophys. Acta 1481:63-74 (2000).
- A. B. Shapiro and V. Ling. Positively cooperative sites for drug transport by P-glycoprotein with distinct drug specificities. Eur. J. Biochem. 250:130-137 (1997).
- E.-J. Wang, C. N. Casciano, R. P. Clement, and W. W. Johnson. Cooperativity in the inhibition of P-glycoprotein-mediated daunorubicin transport: Evidence for half-of-the-sites reactivity. Arch. Biochem. Biophys. 382(2):91-98 (2000).
- D. G. Bailey, J. D. Spence, C. Munoz, and J. M. O. Arnold. Interaction of citrus juices with felodipine and nifedipine. Lancet 337:268-269 (1991).
- M. P. Ducharme, L. H. Warbasse, and D. J. Edwards. Disposition of oral and intravenous cyclosporin after administration with grapefruit juice. Clin. Pharmacol. Ther. 57:485-491 (1995).
- H. H. T. Kupferschmidt, H. R. Ha, W. H. Ziegler, P. J. Meier, and S. Krahenbuhl. Interaction between grapefruit juice and midazolam in humans. Clin. Pharmacol. Ther. 58:20-28 (1995).
- S. K. Hukkinen, A. Varhe, K. T. Olkkola, and P. J. Neuvonen. Plasma concentrations of triazolam are increased by concomitant ingestion of grapefruit juice. Clin. Pharmacol. Ther. 58:127-131 (1995).
- R. E. Benton, P. K. Hoig, K. Zamaani, L. R. Cantilena, and R. L. Woosley. Grapefruit juice alters terfenadine pharmacokinetics, resulting in prolongation of repolarization on the electrocardiogram. Clin. Pharmacol. Ther. 59:383-388 (1996).
- H. H. T. Kupferschmidt, K. E. Fattinger, H. R. Ha, F. Follath, and S. Krahenbuhl. Grapefruit juice enhances the bioavailability of the HIV protease inhibitor saquinavir in man. Br. J. Clin. Pharmacol. 45:355-359 (1998).
- T. Kantola, K. T. Kivisto, and P. J. Neuvonen. Grapefruit juice greatly increases serum concentrations of lovastatin and lovastatin acid. Clin. Pharmacol. Ther. 63:397-402 (1998).
- J. J. Lilja, K. T. Kivisto, and P. J. Neuvonen. Grapefruit juicesimvastatin interaction effect on serum concentrations of simvastatin, simvastatin acid, and HMG-CoA reductase inhibitors. Clin. Pharm. Ther. 64:477-483 (1998).
- J. J. Lilja, K. T. Kivisto, and P. J. Neuvonen. Grapefruit juice increases serum concentrations of atorvastatin and has no effect on pravastatin. Clin. Pharm. Ther. 66:118-127 (1999).
- A. Weber, R. Jager, A. Borner, G. Klinger, R. Vollanth, K. Mathery, and A. Balogh. Can grapefruit juice influence ethinylestradiol bioavailability? Contraception 53:41-47 (1996).
- K. He, K. Iyer, R. N. Hayes, M. W. Sinz, T. F. Woolf, and P. F. Hollenberg. Inactivation of cytochrome P450 3A4 by bergamottin, a component of grapefruit juice. Chem. Res. Toxicol. 11:252-259 (1998).
- A. Miniscalco, J. Lundahl, C. G. Regardh, B. Edgar, and U. G. Eriksson. Inhibition of dihydropyridine metabolism in rat and human liver microsomes by flavonoids found in grapefruit juice. J. Pharmacol. Exp. Ther. 261:1195-1199 (1992).
- A. Ghosal, H. Satoh, P. E. Thomas, E. Bush, and D. Moore. Inhibition and kinetics of cytochrome P450 3A4 activity in microsomes from rat, human and cDNA-expressed human cytochrome P450. Drug Metab. Dispos. 24:940-947 (1996).
- H. Takanaga, A. Ohnishi, H. Matsuo, and Y. Sawada. Inhibition of Vinblastine Efflux mediated by p-glycoprotein by grapefruit juice components in Caco-2 cells. Biol. Pharm. Bull. 21:1062-1066 (1998).
- V. A. Eagling, L. Profit, and D. J. Back. Inhibition of the CYP3A4-mediated metabolism and P-glycoprotein-mediated transport of the HIV-1 protease inhibitor saquinavir by grapefruit juice components. Br. J. Clin. Pharmacol. 48:543-552 (1999).
- E.-J. Wang, C. N. Casciano, R. P. Clement, and W. W. Johnson. In vitro flow cytometry method to quantitatively assess inhibitors of P-glycoprotein. Drug Met. Disp. 28:522-528 (2000).
- S. Chifflet, A. Torriglia, R. Chiesa, and S. Tolosa. A method for the determination of inorganic phosphate in the presence of labile organic phosphate and high concentrations of protein: application to lens ATPases. Analytical Biochem. 168:1-4 (1988).
- A. B. Shapiro and V. Ling. ATPase activity of purified and reconstituted P-glycoprotein from Chinese hamster ovary cells J. Biol. Chem. 269:3745-3754 (1994).
- C. A. Doige, Y. Xiaohong, and F. J. Sharom. ATPase activity of partially purified P-glycoprotein from multidrug-resistant Chinese hamster ovary cells. Biochim. Biophys. Acta 1109:149-160 (1992).
- G. D. Eytan, R. Regev, and Y. G. Assaraf. Functional reconstitution of P-glycoprotein reveals an apparent near stoichiometric drug transport to ATP hydrolysis. J. Biol. Chem. 271:3172-3178 (1996).
- S. V. Ambudkar, C. O. Cardarelli, E. Pashinsky, and W.D. Stein. Relation between the turnover number for vinblastine transport and for vinblastine-stimulated ATP hydrolysis by human P-glycoprotein. J. Biol. Chem. 272:21160-21166 (1997).
- W. D. Stein. Kinetics of the multidrug transporter (P-glycoprotein) and its reversal. Physiol. Rev. 77:545-590 (1997).
- A. B. Shapiro and V. Ling. Stoichiometry of coupling of rhodamine 123 transport to ATP hydrolysis by P-glycoprotein. Eur. J. Biochem. 254:189-193 (1998).
- I. H. Segel. Enzyme Kinetics: Behavior and Analysis of Rapid Equilibrium and Steady-State Enzyme Systems, Wiley-Interscience, New York 1975.
- A. Seelig. A general pattern for substrate recognition by P-glycoprotein. Eur. J. Biochem. 251, 252-261 (1998).
- G. Scambia, F. O. Ranelletti, P. B. Paniici, R. De Vincenzo, G. Bonanno, G. Ferrandina, M. Piantelli, S. Bussa, C. Rumi, M. Cianfriglia, and S. Mancuso. Quercetin potentiates the effect of adriamycin in a multidrug-resistance MCF-7 human breast-cancer cell line: P-glycoprotein as a possible target. Cancer Chemother. Pharmacol. 34:459-464 (1994).
- T. Langguth, S. Neuhoff, C. Regardh, and H. Spahn-Langguth. Grapefruit juice components modify the intestinal permeability of the P-glycoprotein substrate talinolol. Exp. Toxic Pathol. 50:117 (1998).
- U. Fuhr. Drug interactions with grapefruit juice. Extent, probable mechanism and clinical relevance. Drug Saf. 18:251-272 (1998).
- V. Hollt, M. Kouba, M. Dietel, and G. Vogt. Stereoisomers of calcium antagonists which differ markedly in potencies as calcium blockers are equally effective in modulating transport by P-glycoprotein. Biochem. Pharmacol. 43:2601-2608 (1992).
- C. Pascaud, M. Garrigos, and S. Orlowski. Multidrug resistance transporter P-glycoprotein has distinct but interacting binding sites for cytotoxic drugs and reversing agents. Biochem. J. 333(2):351-358 (1998).
- K. S. Lown, R. R. Mayo, A. B. Leichtman, H.-L. Hsiao, D. K. Turgeon, P. Schmiedlin-Ren, M. B. Brown, W. Guo, S. J. Rossi, L. Z. Benet, and P. B. Watkins. Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporin A. Clin. Pharmacol. Ther. 62:248-260 (1997).
- Inhibition of P-Glycoprotein Transport Function by Grapefruit Juice Psoralen
Volume 18, Issue 4 , pp 432-438
- Cover Date
- Print ISSN
- Online ISSN
- Kluwer Academic Publishers-Plenum Publishers
- Additional Links
- drug interaction
- Industry Sectors